JHP president and CEO Stuart Hinchen said customers look at JHP’s established infrastructure to progress products from clinical to commercial supply. ”Additionally, our cGMP compliance record and experienced
Omeros’ proprietary DTLacO technology is an ex vivo antibody discovery platform that pairs an engineered chicken B-cell line with antibody selection strategies and also has antibody repertoire from
The study revealed that the Nanobody’s specific structure, stability and small size made possible the convenient route of administration where antibodies have been unsuccessful. The double-blind, randomized trial
Both vaccines are designed to induce humoral and cellular immune responses that target the circumsporozoite protein antigen of Plasmodium falciparum. Under the grant, Protein Potential will use its
The study enrolled 11 patients to evaluate NiCord as an alternative investigational treatment for HM and is expected to provide the results within six months. Gamida Cell research
The study will assess overall survival (OS) and progression-free survival (PFS) in patients 60 years and older with DLBCL who achieved remission following R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin,
Micropharma president and chief executive officer Ryan Jones said, "By patenting our products like Cardioviva, it helps us guarantee to consumers that they will get a rigorously tested,
Vortex provides users with an out-of the-box filtering, charting, plotting and chemically aware calculations engine, enabling scientists to evaluate large datasets in an intuitive and flexible user interface.
The development was based on a contract basis signed with US Department of Defense (DoD), which is managed by the Joint Project Manager Transformational Medical Technologies (JPM-TMT) Project
Simponi subcutaneous injection is indicated for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Janssen Biotech discovered and developed Simponi as a treatment for inflammatory autoimmune diseases involving TNF
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.